pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Sep 11·1 min read
save

Thoracic surgeon warns that 9/11 exposure continues to cause lung cancer and mesothelioma decades later

Sep 11, 2026·read at STAT ↗Neutral

Raja Flores, a thoracic surgeon at Mount Sinai, treats patients whose illnesses trace back to the dust and fumes of the World Trade Center collapse. He describes how many former first responders and nearby residents now face lung cancer, mesothelioma, and other serious conditions long after the attacks.

One of his patients, retired NYPD officer John Aris, recently returned for a CT scan after having part of his lung removed years earlier. The surgeon’s hopeful words, “No cancer,” underscore the ongoing anxiety that families endure with each follow‑up.

Flores notes that the upcoming 25th anniversary ceremony will include a new moment of silence to honor those who have died from diseases linked to their exposure at Ground Zero, highlighting that the health toll of 9/11 is still unfolding.

The piece serves as a reminder that the medical consequences of the attacks persist, affecting both patients and the broader healthcare community tasked with treating these complex, exposure‑related diseases.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: I’m a thoracic surgeon in New York City. For many of my patients, Sept. 11 is still not over”

read at STAT ↗
1,229 words · retrieved Sep 11
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Oncology17Pulmonology10NSCLC2AsthmaGastroenterologyPsychiatry & CNSVaccine

related stories

  • Sep 10STAT+: FDA expands Bayer lung cancer drug approvalSTAT
  • Jul 2Opinion: CDC leadership continues to try to manufacture a scientific debate on vaccines where none existsSTAT
  • Jul 1FDA says Zyn can market its pouches as safer than cigarettesSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • May 11MimiVax and Roswell Park Open Phase 2 Trial of SurVaxM for Patients with Metastatic Neuroendocrine Tumorsonclive